Fluconazole Related Published Studies
Well-designed clinical trials related to Fluconazole
Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age. [2011.05]
Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. [2011.05]
A pseudo-randomised clinical trial of in situ gels of fluconazole for the treatment of oropharngeal candidiasis. [2011.04.19]
Tecarfarin, a novel vitamin K reductase antagonist, is not affected by CYP2C9 and CYP3A4 inhibition following concomitant administration of fluconazole in healthy participants. [2011.04]
Anidulafungin compared with fluconazole for treatment of candidemia and other
forms of invasive candidiasis caused by Candida albicans: a multivariate analysis
of factors associated with improved outcome. [2011]
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. [2010.12.09]
Study to compare the efficacy and safety of fluconazole cream with flutrimazole cream in the treatment of superficial mycosis: a multicentre, randomised, double-blind, phase III trial. [2010.11]
Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands. [2010.09]
Assessment safety and efficacy of a combination therapy of topical amphotericin B and subconjunctival fluconazole for the treatment of fungal keratitis. [2010.09]
Single-dose oral fluconazole versus topical clotrimazole in patients with pityriasis versicolor: A double-blind randomized controlled trial. [2010.08]
Topical amphotericin B and subconjunctival injection of fluconazole (combination therapy) versus topical amphotericin B (monotherapy) in treatment of keratomycosis. [2010.06]
Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients. [2010.04]
Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi. [2010.02.01]
Co-administration of fluconazole increases nevirapine concentrations in HIV-infected Ugandans. [2010.02]
[Cost benefit analysis for prophylactic use of itraconazole versus fluconazole after hematopoietic stem cell transplantation] [2010.01]
Fluconazole prophylaxis in high-risk neonates. [2010.01]
Comparison of fluconazole and nystatin oral suspensions for prophylaxis of systemic fungal infection in very low birthweight infants. [2010.01]
Single-dose oral fluconazole versus topical clotrimazole in patients with
pityriasis versicolor: A double-blind randomized controlled trial. [2010]
Economic evaluation of posaconazole versus fluconazole prophylaxis in patients
with graft-versus-host disease (GVHD) in the Netherlands. [2010]
Study to compare the efficacy and safety of fluconazole cream with flutrimazole
cream in the treatment of superficial mycosis: a multicentre, randomised,
double-blind, phase III trial. [2010]
Effect of fluconazole on the pharmacokinetics of halofantrine in healthy volunteers. [2009.12]
[Comparison of micafungin and fosfluconazole as prophylaxis for invasive fungal infection during neutropenia in children undergoing chemotherapy and hematopoietic stem cell transplantation] [2009.12]
A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. [2009.06.15]
The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial. [2009.04]
Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. [2009.03]
Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. [2009.02.02]
Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation. [2009.01.05]
A study to evaluate the efficacy and safety of oral fluconazole in the treatment of tinea versicolor. [2009.01]
Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial. [2008.11.15]
Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. [2008.07.15]
Fluconazole prophylaxis: can we eliminate invasive Candida infections in the neonatal ICU? [2008.06]
Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial. [2008.05]
Effect of multiple oral dosing of fluconazole on the pharmacokinetics of cyclosporine in healthy beagles. [2008.01]
Effects of nystatin, fluconazole and propolis on poly(methyl methacrylate) resin surface. [2008]
Fluconazole Prophylaxis against Fungal Colonization and Invasive Fungal Infection in Very Low Birth Weight Infants. [2007.11.07]
[The impact of itraconazol versuse fluconazole on the prevention of postoperative invasive fungal infections after orthotopic liver transplantation] [2007.11]
Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants. [2007.11]
Bioavailability of oral fluconazole in critically ill abdominal trauma patients with and without abdominal wall closure: a randomized crossover clinical trial. [2007.07]
A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. [2007.06.14]
Anidulafungin versus fluconazole for invasive candidiasis. [2007.06.14]
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. [2007.01.25]
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. [2007.01.25]
Effects of three cytochrome P450 inhibitors, ketoconazole, fluconazole, and paroxetine, on the pharmacokinetics of lasofoxifene. [2007.01]
Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients. [2006.08]
Terbinafine versus itraconazole and fluconazole in the treatment of Vulvovaginal candidiasis. [2006.07]
A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients. [2006.07]
Effects of the antifungals voriconazole and fluconazole on the pharmacokinetics of s-(+)- and R-(-)-Ibuprofen. [2006.06]
A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS. [2006.04.15]
Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mg. [2006.04]
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia. [2006.02]
Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies. [2006.01]
Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy. [2006.01]
An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis. [2005.12]
A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40. [2005.11.15]
A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis. [2005.11]
Effect of azole antifungals ketoconazole and fluconazole on the pharmacokinetics of dexloxiglumide. [2005.11]
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. [2005.10.22]
A randomized, open-label pharmacokinetic comparison of two oral formulations of fluconazole 150 mg in healthy adult volunteers. [2005.10]
Fluconazole and/or hexetidine for management of oral candidiasis associated with denture-induced stomatitis. [2005.09]
Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight. [2005.08]
Bioequivalence evaluation of two formulations of fluconazole 150 mg capsule in healthy Arab men. [2005.05]
A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis. [2005.04.01]
Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant. [2005.04]
Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole. [2005.02]
Evaluation of the bioequivalence of capsules containing 150 mg of fluconazole. [2005.01.06]
Well-designed clinical trials possibly related to Fluconazole
Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial. [2010.11]
Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa. [2010.06.01]
[Economic evaluation of posaconazole in prophylaxis of invasive fungal infections in Italian neutropenic patients with acute myeloid leukaemia or myelodysplastic syndrome]. [2010.06]
International collaboration between US and Thailand on a clinical trial of treatment for HIV-associated cryptococcal meningitis. [2010.01]
Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species. [2009.12]
Efungumab: a novel agent in the treatment of invasive candidiasis. [2009.11]
Efungumab: A Novel Agent in the Treatment of Invasive Candidiasis (November). [2009.09.22]
A prospective, randomised study on the use of well-fitting masks for prevention of invasive aspergillosis in high-risk patients. [2009.09]
Double-blind active-control trials: beware the comparator you keep. [2008.10.15]
High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. [2008.07.01]
Conduit artery constriction mediated by low flow a novel noninvasive method for the assessment of vascular function. [2008.05.20]
Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. [2008.05.15]
Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia. [2008.03]
Anidulafungin in the treatment of invasive fungal infections. [2008.02]
Cefpodoxime proxetil compared with cefixime for treatment of typhoid fever in children. [2007.11]
Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis. [2007.10]
Posaconazole: an extended-spectrum triazole antifungal agent. [2007.09]
Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients. [2007.08]
AT1 receptor blockade prevents the decrease in conduit artery flow-mediated dilatation during NOS inhibition in humans. [2007.06]
Tacrolimus powder in Orabase 0.1% for the treatment of oral lichen planus and oral lichenoid lesions: an open clinical trial. [2006.12]
The syndromic management of vaginal discharge using single-dose treatments: a randomized controlled trial in West Africa. [2006.09]
The debate: The trials have told us very little. [2006.09]
Delayed ABLC prophylaxis after allogeneic stem-cell transplantation. [2006.09]
A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients: results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II. [2006.06]
Reducing warfarin medication interactions: an interrupted time series evaluation. [2006.05.08]
Evidence for a basal release of a cytochrome-related endothelium-derived hyperpolarizing factor in the radial artery in humans. [2006.04]
Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimally invasive and noninvasive probes for hepatic and first-pass CYP3A activity. [2005.10]
Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV. [2005.07.20]
The role of CYP2C and CYP3A in the disposition of 3-keto-desogestrel after administration of desogestrel. [2005.07]
Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. [2005.06.15]
Initial treatment of cryptococcal meningitis in AIDS. [2005.01]
Other research related to Fluconazole
Clinical characteristics and response to prophylactic fluconazole of preterm VLBW
neonates with baseline and acquired fungal colonisation in NICU: data from a
multicentre RCT. [2012]
Mould-active compared with fluconazole prophylaxis to prevent invasive fungal
diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell
transplantation: a systematic review and meta-analysis of randomised controlled
trials. [2012]
Cost-effectiveness of posaconazole versus fluconazole for prevention of invasive
fungal infections in U.S. patients with graft-versus-host disease. [2012]
Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial. [2011.12]
Fluconazole but not the CYP3A4 inhibitor, itraconazole, increases zafirlukast plasma concentrations. [2011.11.23]
|
